Project Details
Description
Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer
Status | Finished |
---|---|
Effective start/end date | 9/14/23 → 4/30/24 |
Funding
- THOMAS JEFFERSON UNIVERSITY
- NIH NATIONAL CANCER INSTITUTE (NCI)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.